<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05046678</url>
  </required_header>
  <id_info>
    <org_study_id>318S106</org_study_id>
    <nct_id>NCT05046678</nct_id>
  </id_info>
  <brief_title>miRNAs in Periodontal Disease</brief_title>
  <official_title>Effects of Smoking on Saliva MicroRNAs Before and After Non-Surgical Periodontal Therapy in Patients With Periodontal Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bulent Ecevit University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bulent Ecevit University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been stated that microRNA (miRNA) play an important role in development, homeostasis&#xD;
      and immune functions, and abnormal miRNA expression may cause faster disease progression. The&#xD;
      aim of this study was to determine miR-203, miR-142-3p, miR-146a, miR-146b, miR-155, miR-29b&#xD;
      gene expressions in saliva of the patients with periodontal disease before and after&#xD;
      non-surgical periodontal therapy (NSPT) and to evaluate the effect of smoking on these&#xD;
      miRNAs. A total of 90 individuals, 30 with periodontitis, 30 with gingivitis, and 30&#xD;
      periodontally healthy (control group), were included. These three groups were divided into&#xD;
      subgroups as smoking and non-smoking individuals, with 15 people in each group. NSPT was&#xD;
      applied to patients with periodontitis and gingivitis. Saliva samples and clinical parameters&#xD;
      were taken from at baseline and repeated 6 weeks after NSPT.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">November 1, 2020</completion_date>
  <primary_completion_date type="Actual">September 1, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Weeks</target_duration>
  <primary_outcome>
    <measure>miRNAs gene expressions in the periodontal disease</measure>
    <time_frame>baseline</time_frame>
    <description>miR-203, miR-142-3p, miR-146a, miR-146b, miR-155, miR-29b gene expressions in saliva</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>miRNAs gene expressions in the periodontal disease</measure>
    <time_frame>baseline and 6 weeks after treatment</time_frame>
    <description>miR-203, miR-142-3p, miR-146a, miR-146b, miR-155, miR-29b gene expressions in saliva before and after non-surgical periodontal treatment</description>
  </secondary_outcome>
  <other_outcome>
    <measure>miRNAs gene expressions in the periodontal disease</measure>
    <time_frame>baseline and 6 weeks after treatment</time_frame>
    <description>miR-203, miR-142-3p, miR-146a, miR-146b, miR-155, miR-29b gene expressions in saliva of the individials with smokers and nonsmokers</description>
  </other_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Periodontal Diseases</condition>
  <condition>Periodontitis</condition>
  <condition>Gingivitis</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Periodontally healthy, non-smoking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Smokers with periodontally healthy</arm_group_label>
    <description>Periodontally healthy, smoking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-smokers with gingivitis</arm_group_label>
    <description>Gingivitis, non-smoking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Smokers with gingivitis</arm_group_label>
    <description>Gingivitis, smoking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-smokers with periodontitis</arm_group_label>
    <description>Periodontitis, non-smoking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Smokers with periodontitis</arm_group_label>
    <description>Periodontitis, smoking</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>probing pocket depth (PPD)≤ 3 mm (presence of normal gingival sulcus), bleeding on probing (BOP) &lt; 10%, clinical absence of periodontal inflammation, radiological bone loss, and any prior periodontal disease, additionally presence of anatomically intact periodontium and nonsmokers if they had no previous history of smoking</description>
    <arm_group_label>Non-smokers with gingivitis</arm_group_label>
    <arm_group_label>Non-smokers with periodontitis</arm_group_label>
    <arm_group_label>Smokers with gingivitis</arm_group_label>
    <arm_group_label>Smokers with periodontally healthy</arm_group_label>
    <arm_group_label>Smokers with periodontitis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Smokers with periodontally healthy</intervention_name>
    <description>probing pocket depth (PPD)≤ 3 mm (presence of normal gingival sulcus), bleeding on probing (BOP) &lt; 10%, clinical absence of periodontal inflammation, radiological bone loss, and any prior periodontal disease, additionally presence of anatomically intact periodontium and smokers if they had smoked ≥10 cigarettes/day for ≥5 years</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Non-smokers with gingivitis</arm_group_label>
    <arm_group_label>Non-smokers with periodontitis</arm_group_label>
    <arm_group_label>Smokers with gingivitis</arm_group_label>
    <arm_group_label>Smokers with periodontitis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Non-smokers with gingivitis</intervention_name>
    <description>without attachment and alveolar bone loss who had gingival inflammation, PD ≤ 3 mm and BOP &gt; 30% in the full mouth and nonsmokers if they had no previous history of smoking</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Non-smokers with periodontitis</arm_group_label>
    <arm_group_label>Smokers with gingivitis</arm_group_label>
    <arm_group_label>Smokers with periodontally healthy</arm_group_label>
    <arm_group_label>Smokers with periodontitis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Smokers with gingivitis</intervention_name>
    <description>without attachment and alveolar bone loss who had gingival inflammation, PD ≤ 3 mm and BOP &gt; 30% in the full mouth and smokers if they had smoked ≥10 cigarettes/day for ≥5 years</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Non-smokers with gingivitis</arm_group_label>
    <arm_group_label>Non-smokers with periodontitis</arm_group_label>
    <arm_group_label>Smokers with periodontally healthy</arm_group_label>
    <arm_group_label>Smokers with periodontitis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Non-smokers with periodontitis</intervention_name>
    <description>interdental clinical attachment level (CAL) ≥ 5 mm and PPD ≥ 6 mm on at least two non-adjacent teeth, bone loss involving the middle or apical third of the root radiographically, moderate ridge defect and ≥30% of teeth and nonsmokers if they had no previous history of smoking</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Non-smokers with gingivitis</arm_group_label>
    <arm_group_label>Smokers with gingivitis</arm_group_label>
    <arm_group_label>Smokers with periodontally healthy</arm_group_label>
    <arm_group_label>Smokers with periodontitis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Smokers with periodontitis</intervention_name>
    <description>interdental clinical attachment level (CAL) ≥ 5 mm and PPD ≥ 6 mm on at least two non-adjacent teeth, bone loss involving the middle or apical third of the root radiographically, moderate ridge defect and ≥30% of teeth and smokers if they had smoked ≥10 cigarettes/day for ≥5 years</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Non-smokers with gingivitis</arm_group_label>
    <arm_group_label>Non-smokers with periodontitis</arm_group_label>
    <arm_group_label>Smokers with gingivitis</arm_group_label>
    <arm_group_label>Smokers with periodontally healthy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1. group (Control): Periodontally and systemically healthy and non-smoking&#xD;
&#xD;
          2. group: Periodontally and systemically healthy and smoking&#xD;
&#xD;
          3. group: Gingivitis, Systemically healthy and non-smoking&#xD;
&#xD;
          4. group: Gingivitis, Systemically healthy and smoking&#xD;
&#xD;
          5. group: Periodontitis, Systemically healthy and non-smoking&#xD;
&#xD;
          6. group: Periodontitis, Systemically healthy and smoking&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Have at least 20 natural teeth, excluding third molars. Periodontitis patients had at least&#xD;
        two non-adjacent sites per quadrant with probing depth (PD) ≥ 5 mm and clinical attachment&#xD;
        level (CAL) ≥ 5 mm with gingival inflammation, and alveolar bone loss affecting &gt;30% of the&#xD;
        teeth, as detected on clinical and radiographical examinations.&#xD;
&#xD;
        Gingivitis patients had without attachment and alveolar bone loss who had gingival&#xD;
        inflammation, PD ≤ 3 mm and BOP &gt; 30% in the entire mouth Periodontally healthy control&#xD;
        group had no sign of gingival inflammation, no PD &gt; 3mm and no evidence of attachment or&#xD;
        bone loss&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        History of systemic disease. Regular use of any drugs which can effect the immune system or&#xD;
        inflammatory response in the 6 months preceding the start of the study.&#xD;
&#xD;
        Periodontal treatment during last 6 months that could affect periodontal status.&#xD;
&#xD;
        History of radiotherapy or chemotherapy. Current pregnancy, lactation or menopause.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ordu University</name>
      <address>
        <city>Ordu</city>
        <state>In The USA Or Canada, Please Select...</state>
        <zip>52100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 13, 2021</study_first_submitted>
  <study_first_submitted_qc>September 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bulent Ecevit University</investigator_affiliation>
    <investigator_full_name>Figen Öngöz Dede</investigator_full_name>
    <investigator_title>T.C. ORDU ÜNİVERSİTESİ</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Periodontal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

